Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.
This study is recruiting in Japan. It is testing vortioxetine for depression.
Multiple locations, including Nagoya
This study is recruiting in Netherlands. It focuses on Depression.
In NetherlandsThis study is recruiting in the United States and in Russian Federation. It is testing change for depression.
Multiple locations, including BentonvilleThis study is recruiting in the United States. It is testing change for depression.
Multiple locations, including Dothan
This study is recruiting in the United Kingdom, in Belgium, in Austria, .... It is testing Effectiveness and Efficiency of VNS Therapy for depression.
Multiple locations, including ViennaThis study is recruiting in the United States, in Australia, in Canada, .... It is testing VLS-01 Buccal Film, Compared to Placebo for depression.
Multiple locations, including TucsonThis study is recruiting in Germany. It is testing a digital intervention for depression.
In GermanyThis study is recruiting in the United States. It is testing DT-101 for depression.
Multiple locations, including DeSotoThis study is recruiting in the United States, in the United Kingdom, in Bulgaria, .... It is testing DT-101 for depression.
Multiple locations, including BentonvilleThis study is recruiting in the United States. It focuses on adults with tardive dyskinesia who remain symptomatic while receiving or after stopping a VMAT2 inhibitor.
Multiple locations, including BryantThis study is recruiting in the United States, in Brazil, in Hungary, .... It is testing esketamine for depression.
Multiple locations, including BirminghamThis study is recruiting in the United States, in Bulgaria, in Czech Republic, .... It is testing SPT-300 (GlyphAllo) for depression.
Multiple locations, including Chino